<--- Back to Details
First PageDocument Content
Health / Prevention / Brighton Collaboration / Immunology / National Center for Immunization and Respiratory Diseases / Vaccine Safety Datalink / Vaccine / Influenza vaccine / Vaccination / Medicine / Vaccines / Centers for Disease Control and Prevention
Date: 2013-05-16 09:42:32
Health
Prevention
Brighton Collaboration
Immunology
National Center for Immunization and Respiratory Diseases
Vaccine Safety Datalink
Vaccine
Influenza vaccine
Vaccination
Medicine
Vaccines
Centers for Disease Control and Prevention

Add to Reading List

Source URL: whqlibdoc.who.int

Download Document from Source Website

File Size: 2,58 MB

Share Document on Facebook

Similar Documents

Health / Vaccination schedule / Vaccine Safety Datalink / HPV vaccine / Influenza vaccine / Vaccine / MMRV vaccine / Adverse effect / National Childhood Vaccine Injury Act / Medicine / Vaccines / Vaccination

REVIEW OF THE MANAGEMENT OF ADVERSE EVENTS ASSOCIATED WITH PANVAX AND FLUVAX (HORVATH REVIEW) OUTCOMES OF RECOMMENDATIONS INTRODUCTION Following an increase in febrile convulsions associated with influenza vaccine in chi

DocID: 15MY7 - View Document

REVIEW OF THE MANAGEMENT OF ADVERSE EVENTS ASSOCIATED WITH PANVAX AND FLUVAX (HORVATH REVIEW) OUTCOMES OF RECOMMENDATIONS INTRODUCTION  Following an increase in febrile convulsions associated with influenza vaccine in ch

REVIEW OF THE MANAGEMENT OF ADVERSE EVENTS ASSOCIATED WITH PANVAX AND FLUVAX (HORVATH REVIEW) OUTCOMES OF RECOMMENDATIONS INTRODUCTION Following an increase in febrile convulsions associated with influenza vaccine in ch

DocID: 15MEx - View Document

REVIEW OF THE MANAGEMENT OF ADVERSE EVENTS ASSOCIATED WITH PANVAX AND FLUVAX (HORVATH REVIEW) OUTCOMES OF RECOMMENDATIONS INTRODUCTION  Following an increase in febrile convulsions associated with influenza vaccine in ch

REVIEW OF THE MANAGEMENT OF ADVERSE EVENTS ASSOCIATED WITH PANVAX AND FLUVAX (HORVATH REVIEW) OUTCOMES OF RECOMMENDATIONS INTRODUCTION Following an increase in febrile convulsions associated with influenza vaccine in ch

DocID: 15MwQ - View Document

Health / Vaccination schedule / Vaccine Safety Datalink / HPV vaccine / Influenza vaccine / Vaccine / MMRV vaccine / Adverse effect / National Childhood Vaccine Injury Act / Medicine / Vaccines / Vaccination

REVIEW OF THE MANAGEMENT OF ADVERSE EVENTS ASSOCIATED WITH PANVAX AND FLUVAX (HORVATH REVIEW) OUTCOMES OF RECOMMENDATIONS INTRODUCTION Following an increase in febrile convulsions associated with influenza vaccine in chi

DocID: 15Mmk - View Document

Recommendations Approved by NVAC on June 2, 2009  National Vaccine Advisory Committee (NVAC) Recommendations on the Centers for Disease Control and Prevention Immunization Safety Office Draft 5-Year Scientific Agenda

Recommendations Approved by NVAC on June 2, 2009 National Vaccine Advisory Committee (NVAC) Recommendations on the Centers for Disease Control and Prevention Immunization Safety Office Draft 5-Year Scientific Agenda

DocID: 15bs2 - View Document